B of A Securities Initiates Coverage On CG Oncology with Buy Rating, Announces Price Target of $65
CG Oncology Inc. +2.50% Pre
CG Oncology Inc. CGON | 37.29 37.29 | +2.50% 0.00% Pre |
B of A Securities analyst Charlie Yang initiates coverage on CG Oncology (NASDAQ:
CGON) with a Buy rating and announces Price Target of $65.